AVITA ALERT: Bragar Eagel & Squire, P.C. is Investigating AVITA Medical, Inc. on Behalf of Avita Stockholders and Encourages Investors to Contact the Firm
1. Bragar Eagel & Squire considers claims against RCEL for possible legal violations. 2. Six-month backlog in unpaid claims impacted RCEL's second-quarter demand. 3. RCEL shares dropped approximately 21% following financial results announcement. 4. Unresolved claims have created uncertainty for medical providers using Recell. 5. Investors encouraged to explore legal options for potential stock losses.